Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lansdale, PA
NPI
1053544791
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2010 N Broad St Ste 100
Lansdale, PA, 19446
Phone (215) 997-9441
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
2,734 services
Medicare patients, 2024
592
Average age 74
Drug cost, 2024
$2.8M
8,179 prescriptions
Company payments, 2025
$294
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ram M Jhingan was code J0897 (injection, denosumab, 1 mg), 1,380 times for 18 patients. In total Ram M Jhingan billed 2,734 services in 15 codes, and Medicare paid $135K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 18 | $20.52 | $28K |
| 99214 Office E&M - Established | Office | 948 | 495 | $98.08 | $93K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 140 | 140 | $14.00 | $1,960 |
| 96372 Injection Administration | Office | 102 | 25 | $10.24 | $1,044 |
| 99213 Office E&M - Established | Office | 45 | 41 | $71.58 | $3,221 |
| 99221 Hospital E&M - Initial | Facility | 27 | 26 | $70.81 | $1,912 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 16 | $67.10 | $1,610 |
| 99231 Hospital E&M - Subsequent | Facility | 15 | 13 | $42.22 | $633 |
| 99204 Office E&M - New | Office | 11 | 11 | $120.28 | $1,323 |
By year: 2022 $125K for 2,561 services; 2023 $131K for 2,999 services; 2024 $135K for 2,734 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ram M Jhingan prescribed most often to Medicare patients was Levothyroxine Sodium, with 697 prescriptions and refills. In total Ram M Jhingan wrote 8,179 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 697 | 1,895 | 178 | $7,112 |
| Synthroid Levothyroxine Sodium | 609 | 1,623 | 163 | $63K |
| Metformin Hcl Generic | 391 | 1,076 | 119 | $4,231 |
| Ozempic Semaglutide | 370 | 630 | 104 | $589K |
| Metformin Hcl Er Metformin Hcl | 289 | 823 | 87 | $4,987 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 236 | 571 | 89 | $25K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 232 | 523 | 69 | $31K |
| Jardiance Empagliflozin | 229 | 522 | 61 | $294K |
| Glimepiride Generic | 206 | 592 | 61 | $2,149 |
| Pioglitazone Hcl Generic | 197 | 534 | 55 | $4,025 |
| Farxiga Dapagliflozin Propanediol | 193 | 385 | 44 | $208K |
| Atorvastatin Calcium Generic | 189 | 535 | 55 | $2,649 |
| Rosuvastatin Calcium Generic | 163 | 483 | 54 | $2,708 |
| Tresiba Flextouch U-100 Insulin Degludec | 137 | 287 | 41 | $96K |
| Novolog Flexpen Insulin Aspart | 132 | 320 | 53 | $32K |
Brand drugs: 3,515 claims; generic drugs: 4,026 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ram M Jhingan $294 ($294 in general payments such as food, travel and fees) from 3 companies. The largest payer was Corcept Therapeutics with $237.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.